home / stock / sera / sera news


SERA News and Press, Sera Prognostics Inc.

Stock Information

Company Name: Sera Prognostics Inc.
Stock Symbol: SERA
Market: NASDAQ
Website: seraprognostics.com

Menu

SERA SERA Quote SERA Short SERA News SERA Articles SERA Message Board
Get SERA Alerts

News, Short Squeeze, Breakout and More Instantly...

SERA - SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE PR Newswire SALT LAKE CITY , Feb. 17, 2026 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative p...

SERA - The top-performing pharma and biotech stocks as group sees resurgence

2026-02-13 14:01:58 ET More on pharmaceuticals, biotech Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More BBH: Mature Biotech Exposure, But Limited Growth Ahead XPH: Healthcare Dashboard For January Most and least shorted m...

SERA - Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications

Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications PR Newswire Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions. ...

SERA - Tracking Baker Brothers Portfolio - Q3 2025 Update

2025-12-16 09:19:08 ET This article is part of a series that provides an ongoing analysis of the changes made to Baker Brothers’ 13F stock portfolio on a quarterly basis. It is based on Baker Brothers’ regulatory 13F Form filed on 11/14/2025. The 13F portfolio value in...

SERA - Sera Announces Publication Acceptance for PRIME Study

Sera Announces Publication Acceptance for PRIME Study PR Newswire The PRIME study, one of the largest studies on preterm birth, has been accepted for publication by a medical journal following abstract presentation earlier this year SALT LAKE CITY , Nov. 24, 2025 /PRNewsw...

SERA - Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transformin...

SERA - Sera Prognostics outlines accelerated Medicaid pilot expansion to 13 states as commercialization momentum builds

2025-11-13 19:12:13 ET More on Sera Prognostics Sera Prognostics, Inc. (SERA) Q3 2025 Earnings Call Transcript Sera Prognostics: Few Takers For A Great Product Spells Angst Sera Prognostics, Inc. (SERA) Presents at H.C. Wainwright 27th Annual Global Investment Confer...

SERA - Sera Prognostics, Inc. (SERA) Q3 2025 Earnings Call Transcript

2025-11-13 19:11:33 ET Sera Prognostics, Inc. (SERA) Q3 2025 Earnings Call November 13, 2025 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Sera Prognostics, Inc. (SERA) Q3 2025 Earnings Call Transcript

SERA - Sera Prognostics GAAP EPS of -$0.16 beats by $0.04, revenue of $0.01M misses by $0.09M

2025-11-13 16:10:00 ET More on Sera Prognostics Sera Prognostics: Few Takers For A Great Product Spells Angst Sera Prognostics, Inc. (SERA) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow Seeking Alpha’s Quant Rating on Sera Pr...

SERA - SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Nov. 13, 2025 /PRNewswire/ --  Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnan...

Next 10